{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T07:15:55Z","timestamp":1793517355046,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","award":["not applicable"],"award-info":[{"award-number":["not applicable"]}],"id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P51 OD011092"],"award-info":[{"award-number":["P51 OD011092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["ACI-1928147"],"award-info":[{"award-number":["ACI-1928147"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54475-9","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T10:29:50Z","timestamp":1735554590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5339-140X","authenticated-orcid":false,"given":"Taisuke","family":"Furusho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-4121","authenticated-orcid":false,"given":"Ranjan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0335-3149","authenticated-orcid":false,"given":"Hideyuki","family":"Hakui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Sairavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4283-5424","authenticated-orcid":false,"given":"Kei","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6013-5090","authenticated-orcid":false,"given":"Mia S.","family":"Galbraith-Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7337-5776","authenticated-orcid":false,"given":"Pratheppa","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5608-7167","authenticated-orcid":false,"given":"Shuhua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-3389","authenticated-orcid":false,"given":"Kentaro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4882-6640","authenticated-orcid":false,"given":"Nicole","family":"Andeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Dissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4213-3130","authenticated-orcid":false,"given":"Hiroyuki","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"54475_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li, C. & Samulski, R. J. Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 21, 255\u2013272 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"54475_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang, J. H., Gessler, D. J., Zhan, W., Gallagher, T. L. & Gao, G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct. Target Ther. 9, 78 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"54475_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 380 142\u2013151 (2019).","journal-title":"N. Engl. J. Med."},{"key":"54475_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.7326\/M17-1319","volume":"168","author":"S Lata","year":"2018","unstructured":"Lata, S. et al. Whole-exome sequencing in adults with chronic kidney disease: A pilot study. Ann. Intern Med. 168 100\u2013109 (2018).","journal-title":"Ann. Intern Med."},{"key":"54475_CR5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(10)60236-X","volume":"375","author":"F Hildebrandt","year":"2010","unstructured":"Hildebrandt, F. Genetic kidney diseases. Lancet 375, 1287\u20131295 (2010).","journal-title":"Lancet"},{"key":"54475_CR6","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1681\/ASN.2018040426","volume":"29","author":"Y Ikeda","year":"2018","unstructured":"Ikeda, Y., Sun, Z., Ru, X., Vandenberghe, L. H. & Humphreys, B. D. Efficient gene transfer to kidney mesenchymal cells using a synthetic adeno-associated viral vector. J. Am. Soc. Nephrol. 29, 2287\u20132297 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"54475_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11321-7","volume":"10","author":"JF Lang","year":"2019","unstructured":"Lang, J. F., Toulmin, S. A., Brida, K. L., Eisenlohr, L. C. & Davidson, B. L. Standard screening methods underreport AAV-mediated transduction and gene editing. Nat. Commun. 10, 3415 (2019).","journal-title":"Nat. Commun."},{"key":"54475_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8226","volume":"15","author":"WY Ding","year":"2023","unstructured":"Ding, W. Y. et al. Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome. Sci. Transl. Med. 15, eabc8226 (2023).","journal-title":"Sci. Transl. Med."},{"key":"54475_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI174722","volume":"134","author":"G Wu","year":"2024","unstructured":"Wu, G. et al. Adeno-associated virus-based gene therapy treats inflammatory kidney disease in mice. J. Clin. Invest. 134, e174722 (2024).","journal-title":"J. Clin. Invest."},{"key":"54475_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/gt.2014.35","volume":"21","author":"CJ Rocca","year":"2014","unstructured":"Rocca, C. J., Ur, S. N., Harrison, F. & Cherqui, S. rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study. Gene Ther. 21, 618\u2013628 (2014).","journal-title":"Gene Ther."},{"key":"54475_CR11","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1089\/hum.2019.127","volume":"30","author":"JD Rubin","year":"2019","unstructured":"Rubin, J. D., Nguyen, T. V., Allen, K. L., Ayasoufi, K. & Barry, M. A. Comparison of gene delivery to the kidney by adenovirus, adeno-associated virus, and lentiviral vectors after intravenous and direct kidney injections. Hum. Gene Ther. 30, 1559\u20131571 (2019).","journal-title":"Hum. Gene Ther."},{"key":"54475_CR12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10157-019-01783-w","volume":"23","author":"S Saito","year":"2019","unstructured":"Saito, S. et al. rAAV6-mediated miR-29b delivery suppresses renal fibrosis. Clin. Exp. Nephrol. 23, 1345\u20131356 (2019).","journal-title":"Clin. Exp. Nephrol."},{"key":"54475_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbrc.2018.01.169","volume":"497","author":"LD Asico","year":"2018","unstructured":"Asico, L. D. et al. Nephron segment-specific gene expression using AAV vectors. Biochem. Biophys. Res. Commun. 497, 19\u201324 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"54475_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85888","volume":"1","author":"PR Konkalmatt","year":"2016","unstructured":"Konkalmatt, P. R. et al. Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI Insight 1, e85888 (2016).","journal-title":"JCI Insight"},{"key":"54475_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","volume":"8","author":"P Colella","year":"2018","unstructured":"Colella, P., Ronzitti, G. & Mingozzi, F. Emerging issues in AAV-mediated in vivo gene therapy. Mol. Ther. Methods Clin. Dev. 8, 87\u2013104 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"54475_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4075","volume":"5","author":"K Adachi","year":"2014","unstructured":"Adachi, K., Enoki, T., Kawano, Y., Veraz, M. & Nakai, H. Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing. Nat. Commun. 5, 3075 (2014).","journal-title":"Nat. Commun."},{"key":"54475_CR17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131610","volume":"4","author":"K Pekrun","year":"2019","unstructured":"Pekrun, K. et al. Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors. JCI Insight 4, e131610 (2019).","journal-title":"JCI Insight"},{"key":"54475_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19230-w","volume":"11","author":"J Weinmann","year":"2020","unstructured":"Weinmann, J. et al. Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants. Nat. Commun. 11, 5432 (2020).","journal-title":"Nat. Commun."},{"key":"54475_CR19","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1128\/JVI.00254-08","volume":"82","author":"D Grimm","year":"2008","unstructured":"Grimm, D. et al. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J. Virol. 82, 5887\u20135911 (2008).","journal-title":"J. Virol."},{"key":"54475_CR20","doi-asserted-by":"publisher","first-page":"28814","DOI":"10.1074\/jbc.M113.482380","volume":"288","author":"S Shen","year":"2013","unstructured":"Shen, S. et al. Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency. J. Biol. Chem. 288, 28814\u201328823 (2013).","journal-title":"J. Biol. Chem."},{"key":"54475_CR21","doi-asserted-by":"publisher","first-page":"189ra176","DOI":"10.1126\/scitranslmed.3005708","volume":"5","author":"D Dalkara","year":"2013","unstructured":"Dalkara, D. et al. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci. Transl. Med. 5, 189ra176 (2013).","journal-title":"Sci. Transl. Med."},{"key":"54475_CR22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/mt.2011.3","volume":"19","author":"NM Kotchey","year":"2011","unstructured":"Kotchey, N. M. et al. A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction. Mol. Ther. 19, 1079\u20131089 (2011).","journal-title":"Mol. Ther."},{"key":"54475_CR23","doi-asserted-by":"publisher","first-page":"F947","DOI":"10.1152\/ajprenal.90601.2008","volume":"296","author":"SC Satchell","year":"2009","unstructured":"Satchell, S. C. & Braet, F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am. J. Physiol. Ren. Physiol. 296, F947\u2013F956 (2009).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"54475_CR24","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1681\/ASN.V210s65","volume":"2","author":"H Latta","year":"1992","unstructured":"Latta, H. An approach to the structure and function of the glomerular mesangium. J. Am. Soc. Nephrol. 2, S65\u2013S73 (1992).","journal-title":"J. Am. Soc. Nephrol."},{"key":"54475_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/BF00310191","volume":"176","author":"T Sakai","year":"1987","unstructured":"Sakai, T. & Kriz, W. The structural relationship between mesangial cells and basement membrane of the renal glomerulus. Anat. Embryol. 176, 373\u2013386 (1987).","journal-title":"Anat. Embryol."},{"key":"54475_CR26","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1073\/pnas.1103573108","volume":"108","author":"CH Choi","year":"2011","unstructured":"Choi, C. H., Zuckerman, J. E., Webster, P. & Davis, M. E. Targeting kidney mesangium by nanoparticles of defined size. Proc. Natl. Acad. Sci. USA 108, 6656\u20136661 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54475_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00834-8","volume":"8","author":"L Guo","year":"2017","unstructured":"Guo, L. et al. Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis. Nat. Commun. 8, 878 (2017).","journal-title":"Nat. Commun."},{"key":"54475_CR28","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","volume":"15","author":"MN Rheault","year":"2004","unstructured":"Rheault, M. N. et al. Mouse model of X-linked Alport syndrome. J. Am. Soc. Nephrol. 15, 1466\u20131474 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"54475_CR29","unstructured":"Yu, A. S. L. et al. Brenner & Rector\u2019s the Kidney (Elsevier, Philadelphia, PA, 2020)."},{"key":"54475_CR30","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski, J., Floege, J., Fliser, D., Bohm, M. & Marx, N. Cardiovascular disease in chronic kidney disease: Pathophysiological insights and therapeutic options. Circulation 143, 1157\u20131172 (2021).","journal-title":"Circulation"},{"key":"54475_CR31","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","volume":"304","author":"CD Touchberry","year":"2013","unstructured":"Touchberry, C. D. et al. FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am. J. Physiol. Endocrinol. Metab. 304, E863\u2013E873 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"54475_CR32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/ndt\/gfx332","volume":"33","author":"S Neuburg","year":"2018","unstructured":"Neuburg, S. et al. Genetic background influences cardiac phenotype in murine chronic kidney disease. Nephrol. Dial. Transpl. 33, 1129\u20131137 (2018).","journal-title":"Nephrol. Dial. Transpl."},{"key":"54475_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.1992.390","volume":"42","author":"K Amann","year":"1992","unstructured":"Amann, K. et al. Reduced capillary density in the myocardium of uremic rats-a stereological study. Kidney Int. 42, 1079\u20131085 (1992).","journal-title":"Kidney Int."},{"key":"54475_CR34","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2005-08-3229","volume":"107","author":"CD Scallan","year":"2006","unstructured":"Scallan, C. D. et al. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. Blood 107, 1810\u20131817 (2006).","journal-title":"Blood"},{"key":"54475_CR35","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/mt.2011.72","volume":"19","author":"SJ Gray","year":"2011","unstructured":"Gray, S. J. et al. Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol. Ther. 19, 1058\u20131069 (2011).","journal-title":"Mol. Ther."},{"key":"54475_CR36","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.2174\/138161208784705504","volume":"14","author":"DJ Begley","year":"2008","unstructured":"Begley, D. J., Pontikis, C. C. & Scarpa, M. Lysosomal storage diseases and the blood-brain barrier. Curr. Pharm. Des. 14, 1566\u20131580 (2008).","journal-title":"Curr. Pharm. Des."},{"key":"54475_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/gt.2012.101","volume":"20","author":"SJ Gray","year":"2013","unstructured":"Gray, S. J., Nagabhushan Kalburgi, S., McCown, T. J. & Jude Samulski, R. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther. 20, 450\u2013459 (2013).","journal-title":"Gene Ther."},{"key":"54475_CR38","first-page":"363","volume":"21","author":"DW Burdon","year":"1971","unstructured":"Burdon, D. W. Immunoglobulins of normal human urine and urethral secretions. Immunology 21, 363\u2013368 (1971).","journal-title":"Immunology"},{"key":"54475_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000333071","volume":"1","author":"DC Chung","year":"2011","unstructured":"Chung, D. C. et al. Adeno-associated virus-mediated gene transfer to renal tubule cells via a retrograde ureteral approach. Nephron Extra 1, 217\u2013223 (2011).","journal-title":"Nephron Extra"},{"key":"54475_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/hgtb.2018.148","volume":"29","author":"X Shen","year":"2018","unstructured":"Shen, X. et al. Transparenchymal renal pelvis injection of recombinant adeno-associated virus serotype 9 vectors is a practical approach for gene delivery in the kidney. Hum. Gene Ther. Methods 29, 251\u2013258 (2018).","journal-title":"Hum. Gene Ther. Methods"},{"key":"54475_CR41","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.kint.2018.11.028","volume":"95","author":"JZ Clark","year":"2019","unstructured":"Clark, J. Z. et al. Representation and relative abundance of cell-type selective markers in whole-kidney RNA-Seq data. Kidney Int. 95, 787\u2013796 (2019).","journal-title":"Kidney Int."},{"key":"54475_CR42","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1152\/ajprenal.00164.2016","volume":"311","author":"RL Chevalier","year":"2016","unstructured":"Chevalier, R. L. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am. J. Physiol. Ren. Physiol. 311, F145\u2013F161 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"54475_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"K Meyer","year":"2015","unstructured":"Meyer, K. et al. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates. Mol. Ther. 23, 477\u2013487 (2015).","journal-title":"Mol. Ther."},{"key":"54475_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.omtm.2017.09.006","volume":"8","author":"KA Quirin","year":"2018","unstructured":"Quirin, K. A. et al. Safety and efficacy of AAV retrograde pancreatic ductal gene delivery in normal and pancreatic cancer mice. Mol. Ther. Methods Clin. Dev. 8, 8\u201320 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"54475_CR45","doi-asserted-by":"publisher","first-page":"1001263","DOI":"10.3389\/fimmu.2022.1001263","volume":"13","author":"W Shen","year":"2022","unstructured":"Shen, W., Liu, S. & Ou, L. rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis. Front. Immunol. 13, 1001263 (2022).","journal-title":"Front. Immunol."},{"key":"54475_CR46","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/mt.2010.71","volume":"18","author":"S Schievenbusch","year":"2010","unstructured":"Schievenbusch, S. et al. Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis. Mol. Ther. 18, 1302\u20131309 (2010).","journal-title":"Mol. Ther."},{"key":"54475_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","volume":"6","author":"JB Kopp","year":"2020","unstructured":"Kopp, J. B. et al. Podocytopathies. Nat. Rev. Dis. Prim. 6, 68 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"54475_CR48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.kint.2016.07.038","volume":"91","author":"J Babickova","year":"2017","unstructured":"Babickova, J. et al. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney Int. 91, 70\u201385 (2017).","journal-title":"Kidney Int."},{"key":"54475_CR49","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.omtm.2022.09.017","volume":"27","author":"M Horiuchi","year":"2022","unstructured":"Horiuchi, M. et al. Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors. Mol. Ther. Methods Clin. Dev. 27, 272\u2013280 (2022).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"54475_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.omtm.2019.05.014","volume":"14","author":"A Kruzik","year":"2019","unstructured":"Kruzik, A. et al. Prevalence of anti-adeno-associated virus immune responses in international cohorts of healthy donors. Mol. Ther. Methods Clin. Dev. 14, 126\u2013133 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"54475_CR51","doi-asserted-by":"publisher","first-page":"E4812","DOI":"10.1073\/pnas.1704766114","volume":"114","author":"LV Tse","year":"2017","unstructured":"Tse, L. V. et al. Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion. Proc. Natl. Acad. Sci. USA 114, E4812\u2013E4821 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54475_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06621-3","volume":"9","author":"A Meliani","year":"2018","unstructured":"Meliani, A. et al. Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nat. Commun. 9, 4098 (2018).","journal-title":"Nat. Commun."},{"key":"54475_CR53","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1182\/bloodadvances.2019000380","volume":"3","author":"D Salas","year":"2019","unstructured":"Salas, D. et al. Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates. Blood Adv. 3, 2632\u20132641 (2019).","journal-title":"Blood Adv."},{"key":"54475_CR54","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-020-0911-7","volume":"26","author":"C Leborgne","year":"2020","unstructured":"Leborgne, C. et al. IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies. Nat. Med. 26, 1096\u20131101 (2020).","journal-title":"Nat. Med."},{"key":"54475_CR55","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139881","volume":"5","author":"ZC Elmore","year":"2020","unstructured":"Elmore, Z. C., Oh, D. K., Simon, K. E., Fanous, M. M. & Asokan, A. Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme. JCI Insight 5, e139881 (2020).","journal-title":"JCI Insight"},{"key":"54475_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000514314","volume":"145","author":"A Cai","year":"2021","unstructured":"Cai, A., Chatziantoniou, C. & Calmont, A. Vascular permeability: Regulation pathways and role in kidney diseases. Nephron 145, 297\u2013310 (2021).","journal-title":"Nephron"},{"key":"54475_CR57","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41588-021-00946-4","volume":"53","author":"K Dong","year":"2021","unstructured":"Dong, K. et al. Renal plasticity revealed through reversal of polycystic kidney disease in mice. Nat. Genet. 53, 1649\u20131663 (2021).","journal-title":"Nat. Genet."},{"key":"54475_CR58","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1681\/ASN.2013070798","volume":"25","author":"X Lin","year":"2014","unstructured":"Lin, X., Suh, J. H., Go, G. & Miner, J. H. Feasibility of repairing glomerular basement membrane defects in Alport syndrome. J. Am. Soc. Nephrol. 25, 687\u2013692 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"54475_CR59","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41586-024-07710-8","volume":"632","author":"H Tasfaout","year":"2024","unstructured":"Tasfaout, H. et al. Split intein-mediated protein trans-splicing to express large dystrophins. Nature 632, 192\u2013200 (2024).","journal-title":"Nature"},{"key":"54475_CR60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJMoa1908490","volume":"382","author":"KJ Pasi","year":"2020","unstructured":"Pasi, K. J. et al. Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A. N. Engl. J. Med. 382, 29\u201340 (2020).","journal-title":"N. Engl. J. Med."},{"key":"54475_CR61","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","volume":"77","author":"JR Mendell","year":"2020","unstructured":"Mendell, J. R. et al. Assessment of systemic delivery of rAAVrh74.MHCK7.micro-dystrophin in children with duchenne muscular dystrophy: A nonrandomized controlled trial. JAMA Neurol. 77, 1122\u20131131 (2020).","journal-title":"JAMA Neurol."},{"key":"54475_CR62","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","volume":"390","author":"EA Pierce","year":"2024","unstructured":"Pierce, E. A. et al. Gene editing for CEP290-associated retinal degeneration. N. Engl. J. Med. 390, 1972\u20131984 (2024).","journal-title":"N. Engl. J. Med."},{"key":"54475_CR63","doi-asserted-by":"publisher","first-page":"e01980","DOI":"10.1128\/JVI.01980-16","volume":"91","author":"LF Earley","year":"2017","unstructured":"Earley, L. F. et al. Adeno-associated Virus (AAV) assembly-activating protein is not an essential requirement for capsid assembly of AAV serotypes 4, 5, and 11. J. Virol. 91, e01980\u201316 (2017).","journal-title":"J. Virol."},{"key":"54475_CR64","first-page":"56324","volume":"131","author":"LE Woodard","year":"2018","unstructured":"Woodard, L. E. et al. Hydrodynamic renal pelvis injection for non-viral expression of proteins in the kidney. J. Vis. Exp. 131, 56324 (2018).","journal-title":"J. Vis. Exp."},{"key":"54475_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66596-4","volume":"10","author":"K Adachi","year":"2020","unstructured":"Adachi, K. et al. Adeno-associated virus-binding antibodies detected in cats living in the Northeastern United States lack neutralizing activity. Sci. Rep. 10, 10073 (2020).","journal-title":"Sci. Rep."},{"key":"54475_CR66","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.kint.2019.11.021","volume":"97","author":"T Furusho","year":"2020","unstructured":"Furusho, T. et al. Renal TNF\u03b1 activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease. Kidney Int. 97, 713\u2013727 (2020).","journal-title":"Kidney Int."},{"key":"54475_CR67","doi-asserted-by":"crossref","unstructured":"Smith, R. O. et al. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin. Elife 9, e54056 (2020).","DOI":"10.7554\/eLife.54056"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54475-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:03:10Z","timestamp":1735560190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54475-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54475"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54475-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.07.28.548760","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"17 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.A. and H.N. receive a royalty of AAV-related technologies licensed by Takara Bio Inc. and Capsigen Inc. H.N. serves as a consultant for biotech companies, is a co-founder of Capsigen Inc., and holds shares of Capsigen Inc. and Sphere Gene Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10728"}}